[go: up one dir, main page]

FI70220B - Foerfarande foer framstaellning av en ny som antibakteriellt medel anvaendbara alfa-substituerad ureidobensylpenicillansyra - Google Patents

Foerfarande foer framstaellning av en ny som antibakteriellt medel anvaendbara alfa-substituerad ureidobensylpenicillansyra Download PDF

Info

Publication number
FI70220B
FI70220B FI812395A FI812395A FI70220B FI 70220 B FI70220 B FI 70220B FI 812395 A FI812395 A FI 812395A FI 812395 A FI812395 A FI 812395A FI 70220 B FI70220 B FI 70220B
Authority
FI
Finland
Prior art keywords
acid
formula
group
hydroxyl
compound
Prior art date
Application number
FI812395A
Other languages
English (en)
Finnish (fi)
Other versions
FI812395L (fi
FI70220C (fi
Inventor
Nobuhiro Oi
Bunya Aoki
Teizo Shinozaki
Kanji Moro
Toshio Kuroki
Isao Matsunaga
Takao Nato
Toshiyuki Nebashi
Yusuke Harada
Hisao Endo
Takao Kimura
Kana Kojima
Masahiko Matsumoto
Hiroshi Okazaki
Haruki Ogawa
Minoru Shindo
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Publication of FI812395L publication Critical patent/FI812395L/fi
Application granted granted Critical
Publication of FI70220B publication Critical patent/FI70220B/fi
Publication of FI70220C publication Critical patent/FI70220C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • C07D499/21Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring with a nitrogen atom directly attached in position 6 and a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D499/44Compounds with an amino radical acylated by carboxylic acids, attached in position 6
    • C07D499/48Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical
    • C07D499/58Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical
    • C07D499/64Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms
    • C07D499/68Compounds with an amino radical acylated by carboxylic acids, attached in position 6 with a carbon chain, substituted by hetero atoms or by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, attached to the carboxamido radical substituted in alpha-position to the carboxamido radical by nitrogen atoms with aromatic rings as additional substituents on the carbon chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D499/00Heterocyclic compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. penicillins, penems; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)

Claims (7)

1. Förfarande för framställning av en ny, som antibakteriellt medel användbarc*-substituerad ureidobensyl-5 penicillansyra med formeln (I): HO—C // CO-N-CONH-CH-CONH —I-S S''V'CH3 (I) „ -^ί Λ I1 väri R^ är väte eller hydroxyl, X är en C _I.-alkyl och Y är 2. b 3 15 en substituent för X och Y är -OR , -CN, -COOR , -fl—J eller 2 i vilka R är väte, en C^_^-alkyl, en C^^-alkanoyl eller en 20 C2_^-alkyl, som är substituerad med en hydroxylgrupp, R^ är en C^_4~alkyl, n är 2, dä Y är -OR2, och 1, dä Y är nägon av de andra grupperna, eller för framställning av ett farmaceutiskt godtagbart sait därav, kännetecknat därav, att 25 a) enc<-substituerad ureidofenylättiksyra med formeln (II) : R6 \ λ-CON-CONH-CH-COOH (II) - i- 6 I11 väri R** är väte, hydroxyl eller en skyddad hydroxylgrupp, R^ är hydroxyl eller en skyddad hydroxylgrupp, Y* är 35 antingen samma som Y i formeln (I) eller Y, som innehäller en skyddad hydroxyl- eller karboxylgrupp och X är samma som X i formeln (I), eller ett reaktivt derivat därav, bringas 38 70220 att reagera med en 6-aminopenicillansyra med formeln (III) : S ch3 5 “2ΝΊ ( YCH, 11111 -N -^ 3 O COOR väri R7 är väte eller en skyddsgrupp, eller ett reaktivt derivat därav, i ett inert organiskt lösningsmedel, och 10 skyddsgruppen, om en sädan finns i R^, R8, R7 eller Y^, avlägsnas, eller b) en N-bensoylkarbaminsyrahalogenid med formeln (IV):
15 R8--CON-CO-Z (IV) Ji/ I 2 R y 8. väri R är en skyddad hydroxylgrupp, Y är antingen samma 20 som Y i formeln (I) eller Y, som innehäller en skyddad hydroxyl- eller karboxylgrupp, och Z är en halogen, bringas att reagera med ett<X-aminobensylpenicillin med formeln (V):
25 H2N-CH-CONH^-N<CH3 J-N -\CH3 _ (V) Γ J O COOR7 T1 11 7 30 väri R och R anger samma som ovan, eller ett reaktivt derivat därav, i ett organiskt lösningsmedel, och varje skyddsgrupp som är närvarande i den erhällna produkten avlägsnas, och om s& Önskas, omvandlas den erhällna föreningen till 35 ett salt.
2. Förfarande enligt patentkravet 1 (a), känne-t e c k n a t därav, att en syrahalogenid av denO<.- II
FI812395A 1980-08-05 1981-07-31 Foerfarande foer framstaellning av en ny som antibakteriellt medel anvaendbara alfa-substituerad ureidobensylpenicillansyra FI70220C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10677580 1980-08-05
JP10677580A JPS5732289A (en) 1980-08-05 1980-08-05 Alpha-substituted ureidobenzylpenicillin

Publications (3)

Publication Number Publication Date
FI812395L FI812395L (fi) 1982-02-06
FI70220B true FI70220B (fi) 1986-02-28
FI70220C FI70220C (fi) 1986-09-15

Family

ID=14442271

Family Applications (1)

Application Number Title Priority Date Filing Date
FI812395A FI70220C (fi) 1980-08-05 1981-07-31 Foerfarande foer framstaellning av en ny som antibakteriellt medel anvaendbara alfa-substituerad ureidobensylpenicillansyra

Country Status (14)

Country Link
US (1) US4355038A (sv)
EP (1) EP0045523B1 (sv)
JP (1) JPS5732289A (sv)
KR (2) KR850000049B1 (sv)
AT (1) ATE10635T1 (sv)
AU (1) AU542522B2 (sv)
CA (1) CA1203530A (sv)
DE (1) DE3167610D1 (sv)
DK (1) DK159272C (sv)
FI (1) FI70220C (sv)
IL (1) IL63456A (sv)
MX (1) MX6943E (sv)
NO (1) NO158300C (sv)
ZA (1) ZA815222B (sv)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5810585A (ja) * 1981-07-10 1983-01-21 Chugai Pharmaceut Co Ltd α−置換ウレイドベンジルペニシラン酸
GB2168975A (en) * 1984-12-20 1986-07-02 Procter & Gamble Amides and compositions thereof having anti-inflammatory and analgesic activity
JPH06159622A (ja) * 1992-11-19 1994-06-07 Miura Kenkyusho:Kk 燃焼ガス自己循環式気化燃焼バーナ

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE32700B1 (en) 1968-02-03 1973-10-31 Beecham Group Ltd Penicillins
GB1250611A (sv) 1968-02-03 1971-10-20
DE1770620A1 (de) 1968-06-12 1971-11-11 Bayer Ag Neue Penicilline
US3939149A (en) * 1970-05-25 1976-02-17 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3959258A (en) * 1970-05-25 1976-05-25 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3974140A (en) * 1970-05-25 1976-08-10 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3936442A (en) * 1970-05-25 1976-02-03 Bayer Aktiengesellschaft Unreidoacetamido-penicilins
US4016282A (en) * 1970-05-25 1977-04-05 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
US3978223A (en) * 1970-05-25 1976-08-31 Bayer Aktiengesellschaft Ureidoacetamido-penicillins for treating bacterial infections
CH562249A5 (sv) 1970-05-25 1975-05-30 Bayer Ag
US3933795A (en) * 1970-05-25 1976-01-20 Hans-Bodo Konig Ureidoacetamido-penicillins
US3980792A (en) * 1970-05-25 1976-09-14 Bayer Aktiengesellschaft Ureidoacetamido-penicillins
GB1433131A (en) * 1972-03-13 1976-04-22 Astra Laekemedel Ab Penicillins
DE2258973A1 (de) 1972-12-01 1974-06-06 Bayer Ag Penicilline, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
GB1562802A (en) 1976-06-26 1980-03-19 Beecham Group Ltd Pharmaceutical compositions containing containing clavulanic acid
JPS54163590A (en) * 1978-06-13 1979-12-26 Chugai Pharmaceutical Co Ltd Penicilunic acid derivative and salt thereof
JPS5524135A (en) * 1978-08-11 1980-02-21 Chugai Pharmaceut Co Ltd Penicillin derivative and its preparation
CA1133896A (en) * 1978-05-26 1982-10-19 Nobuhiro Oi Penicillanic acid derivative and process for preparing the same
JPS54154782A (en) * 1978-05-26 1979-12-06 Chugai Pharmaceut Co Ltd Penicillin derivative and its salt
US4240960A (en) * 1979-03-19 1980-12-23 Bristol-Myers Company Trimethylsilyl substituted penicillins
JPS5583789A (en) 1978-12-18 1980-06-24 Bristol Myers Co Preparation of penicillin

Also Published As

Publication number Publication date
JPS5732289A (en) 1982-02-20
CA1203530A (en) 1986-04-22
FI812395L (fi) 1982-02-06
DE3167610D1 (en) 1985-01-17
IL63456A (en) 1984-12-31
FI70220C (fi) 1986-09-15
DK159272C (da) 1991-02-18
NO812630L (no) 1982-02-08
EP0045523B1 (en) 1984-12-05
US4355038A (en) 1982-10-19
EP0045523A1 (en) 1982-02-10
DK343481A (da) 1982-02-06
NO158300C (no) 1988-08-17
AU542522B2 (en) 1985-02-21
DK159272B (da) 1990-09-24
ATE10635T1 (de) 1984-12-15
KR850000049B1 (ko) 1985-02-14
MX6943E (es) 1986-12-17
ZA815222B (en) 1982-08-25
JPH0118916B2 (sv) 1989-04-07
AU7354981A (en) 1982-02-11
NO158300B (no) 1988-05-09
IL63456A0 (en) 1981-10-30
KR850000048B1 (ko) 1985-02-14
KR830006306A (ko) 1983-09-20

Similar Documents

Publication Publication Date Title
KR840000105B1 (ko) 메탄디올의 페니실린 및 페니실란산 1, 1-디옥사이드와의 비스-에스테르 제조방법
JPH04261185A (ja) セファロスポリン化合物
JP2002514175A (ja) 医薬化合物群
FI63035B (fi) Foerfarande foer framstaellning av 7-alfa-aminoacyl-3-klorcefalosporinderivat
US4182711A (en) Antibacterial agents of the β-lactam type
US4155912A (en) 2-Methylpenem-3-carboxylic acid antibiotics
FI70220B (fi) Foerfarande foer framstaellning av en ny som antibakteriellt medel anvaendbara alfa-substituerad ureidobensylpenicillansyra
CH628900A5 (fr) Procede de preparation de thio-oximes derivees de cephalosporines et de penicillines.
KR870000528B1 (ko) 3-아지도 세팔로스포린의 제조방법
EP0122154A2 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
GB2137997A (en) Improvements in or relating to indolylglycyl cephalosporin derivatives
EP0122158A2 (en) Improvements in or relating to benzothienyl cephalosporin antibiotics
JPH0328438B2 (sv)
JPS643865B2 (sv)
US4192801A (en) Novel phosphorane intermediates for use in preparing penem antibiotics
US5106842A (en) Antibiotic c-3 cyclobutenedione substituted (1-carba)cephalosporin compounds, compositions, and methods of use thereof
US4169833A (en) Novel phosphorane intermediates for use in preparing penem antibiotics
PL112873B1 (en) Process for preparing novel derivatives of 7-aminocephalosporanic acid
US5206360A (en) Intermediates for cyclobutenedione substituted (1-carba)cephalosporin compounds
SU1047392A3 (ru) Способ получени производных цефалоспорина
US5169843A (en) Antibiotic C-3 cyclobutenedione substituted (1-carba) cephalosporin compounds, cmpositions, and methods of use thereof
EP0122156A2 (en) Improvements in or relating to benzothienylglycyl cephalosporin derivatives
CA1108135A (en) Antibacterial agents
US5242913A (en) Substituted 3-cephem compounds as antibacterial agents
KR800001684B1 (ko) 세팔로스포린 유도체의 제조방법

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: CHUGAI SEIYAKU KABUSHIKI KAISHA